What is the recommended treatment for hypertension in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hypertension in Pregnancy

For hypertension in pregnancy, first-line treatment includes oral methyldopa, labetalol, or nifedipine, with the goal of maintaining blood pressure between 110-140/85 mmHg to reduce maternal complications while avoiding fetal compromise. 1, 2

Classification of Hypertension in Pregnancy

  • Hypertension in pregnancy is classified as: chronic hypertension (present before 20 weeks), gestational hypertension (arising after 20 weeks without proteinuria), or preeclampsia (hypertension with proteinuria after 20 weeks) 1
  • Severe hypertension is defined as blood pressure >160/110 mmHg and requires urgent treatment 1

Treatment of Severe Hypertension (>160/110 mmHg)

  • Severe hypertension requires urgent treatment in a monitored setting to prevent maternal complications such as stroke 1
  • First-line medications for severe hypertension include:
    • Oral nifedipine: 10 mg, which can be repeated every 20 minutes to a maximum of 30 mg 3
    • IV labetalol: initial 20 mg bolus, then 40 mg if needed after 10 minutes, followed by 80 mg every 10 minutes to a maximum of 220 mg 3
    • IV hydralazine: 5 mg bolus, then 10 mg every 20-30 minutes to a maximum of 25 mg 3
  • Oral labetalol may be used if IV medications are unavailable 1
  • Recent evidence suggests nifedipine may be superior to hydralazine for successful treatment of severe hypertension (OR 4.13 [95% CrI 1.01-20.75]) 4

Treatment of Non-Severe Hypertension (140-159/90-109 mmHg)

  • Blood pressure consistently at or above 140/90 mmHg should be treated, aiming for a target diastolic BP of 85 mmHg (and systolic BP of 110-140 mmHg) 1
  • First-line oral medications include:
    • Methyldopa: has the longest safety record with long-term infant outcome data 2, 5
    • Labetalol: effective alternative with good safety profile, but contraindicated in women with reactive airway disease 2, 1
    • Extended-release nifedipine: offers once-daily dosing which improves adherence 2, 1
  • Second or third-line agents include hydralazine and prazosin 1
  • Antihypertensive drugs should be reduced or ceased if diastolic BP falls below 80 mmHg 1

Medications to Avoid in Pregnancy

  • ACE inhibitors, angiotensin II receptor blockers (ARBs), direct renin inhibitors, and mineralocorticoid receptor antagonists are contraindicated throughout pregnancy due to fetotoxicity 2, 6
  • Diuretics should generally be avoided as they may reduce uteroplacental perfusion 2
  • Beta-blockers, particularly atenolol, should be used with caution, especially in early pregnancy 2, 6

Management Based on Hypertension Type

Chronic Hypertension

  • Continue antihypertensive medication but switch from contraindicated medications (ACE inhibitors, ARBs) to pregnancy-safe alternatives before conception or as soon as pregnancy is confirmed 2
  • Regular monitoring of maternal and fetal well-being is essential 1

Gestational Hypertension and Preeclampsia

  • More intensive monitoring is required, including assessment for proteinuria and other signs of preeclampsia 1
  • Women with preeclampsia who have severe hypertension or neurological symptoms should receive magnesium sulfate for seizure prophylaxis 1
  • Consider delivery at 37 weeks or earlier if there are complications such as severe uncontrolled hypertension, progressive organ dysfunction, or fetal compromise 1

Postpartum Management

  • Blood pressure should be monitored closely after delivery, with recordings shortly after birth and again within 6 hours 1
  • Antihypertensive medications may need to be continued postpartum and should be withdrawn slowly over days 1
  • NSAIDs for postpartum analgesia should be avoided in women with preeclampsia 1
  • All women should be reviewed at 3 months postpartum to ensure BP and any laboratory abnormalities have normalized 1

Recent Evidence on Comparative Efficacy

  • A 2019 randomized controlled trial comparing oral nifedipine, labetalol, and methyldopa for severe hypertension found that nifedipine resulted in better blood pressure control (84%) compared to methyldopa (76%) 7
  • A network meta-analysis confirmed that nifedipine was superior to hydralazine for successful treatment of severe hypertension without increased risk for cesarean delivery or maternal side effects 4

Long-term Considerations

  • Women with hypertension during pregnancy have increased risk of developing cardiovascular disease later in life 2
  • Annual medical review is advised life-long, with emphasis on healthy lifestyle including exercise, proper nutrition, and maintaining ideal body weight 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.